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The mitoTEMPO dosage was chosen from results described in mice (Vendrov et al. 194 2015) , from a precedent pilot study in zebra finches, and also from an experiment in red 195 crossbills (see also SM). 196 Blood samples, digital pictures of the bill, and body mass measures were taken 197 five days before the implant date and again on the last day of the experiment. Blood 198 samples were stored in a cold box and centrifuged 10 min at 12,000 rpm within 8h of 199 sampling. Plasma was stored at -80ºC until analyses. Body condition (i.e. std. residuals 200 of tarsus length on body mass) was similarly distributed among the treatments and its 201 interaction (all χ 2 tests: p > 0.10). The treatments were randomly distributed across the 202 aviary (cage rows and columns). Nonetheless, the two birds in each cage belonged to the 203 same antioxidant treatment. The identity of the cage was, anyway, included as a random 204 term in all statistical models to control for pseudo-replication. One bird (T3-1 and 205 mitoTEMPO-treated) died by unknown reasons the day after the start of the experiment 206 and was removed from the dataset. 207
Finally, the occurrence of a body feather moult was visually established at the end 208 of the experiment by the same observer (AC). Birds were classified as engaged or not in 209 moult (49 vs 36%, respectively). 210 211 Thyroid hormone analyses 212 T3 levels were assessed from one plasma aliquot obtained in the last blood sampling 213 event. Hormone values were measured by means of commercial species-independent 214 see also SM). 217 218
Respiratory frequency 219
With the aim of validating the hypermetabolic effect of thyroid hormones (e.g. Harper & 220 Seifert 2008), the respiratory frequency was measured just before each blood sampling 221 event by the same observer (AC). The number of breast movements in 90 seconds was 222 counted by handing each bird face up at the left hand, with the head between the middle 223 and forefinger (Fucikova et al. 2009 Expression values of target genes are traditionally corrected to the expression of the 249 control gene using a ΔCt approach, but this assumes that the expression of the control 250 gene is kept constant across conditions. Since our experiment is likely to influence overall 251 homeostasis, and therefore impact control gene expression, we obtained normalized Ct 252 values using the method of Cui et al. four-level factor), the antioxidant treatment (two levels), and the location of the bird into 281 the cage (right vs. left side), as well as their interactions, were all tested in every model 282 (also SM). The cage identity was included as a random factor and was non-significant (all 283 p-values > 0.20), except in the bill redness models (p < 0.01). Similarly, the laboratory 284 session in T3 and carotenoid analyses (microplate identity) were included as another 285 random factor in models testing T3 and carotenoid plasma values, respectively, and they 286 were also non-significant (three and four-level factor, respectively; all p-values > 0.22). 287
In any event, random factors were maintained in all the models for coherence (see e.g. Some covariates were tested. In those models testing the body mass difference, 290 the tarsus length was added to test size-independent variability. Bill brightness was 291 included in the bill redness model to avoid the influence of the total amount (intensity) of 292 light reflected from the measured surface (McGraw 2006) . This allows discarding the 293 influence of tissue structure (i.e. not pigmentation) on redness values (McGraw 2006) . 294
The bill area used to measure the redness was also tested. 295
The initial value of the dependent variable was additionally included as a covariate 296 to avoid subtle initial biases. In this regard, the initial redness was calculated as the 297 standardized residuals obtained from a model including the random factor cage identity 298 as well as bill brightness and surface as covariates (all significant terms, p < 0.02). All 299 the models were explored by backward and forward stepwise procedures, removing or 300 including terms (p > 0.05 or p ≤ 0.05, respectively) to obtain the best fitted one. The 301 lowest AIC criterion also agreed with this procedure. LSD post hocs were used for 302 pairwise comparisons. Plasma T3 and carotenoid values were log-transformed to attain 303 normality. Satterthwaite DFs were used. Least square means ± standard error (LSM ± SE 304 hereon) from mixed models are reported, excepting for moult occurrence were raw 305 proportions are given. 306
307
Results 308
Thyroid hormone levels 309
The mitoTEMPO treatment or its interaction with T3 treatment did not report significant 310 effects on plasma T3 values (both removed at p > 0.78). The backward procedure led to 311 a non-significant T3 treatment factor (i.e. F3,63.3=1.50, p = 0.184). Nonetheless, T3-2 and 312 T3-3 showed a trend to significantly higher values of plasma T3 than controls (LSD 313 pairwise comparisons: p = 0.073 and 0.059, respectively; Figure 1A ). When comparing controls versus the other birds grouped in a single group, a significant effect was detected 315 (F1,67.3=4.07, p =0.048; LSM ± SE: 6.66 ± 1.01 and 9.04 ± 0.60 ng/mL, respectively). 316 317
Respiratory frequency 318
In the model testing respiratory frequency, only the T3 treatment effect remained (F3,70.7 319 = 8.64, p < 0.001; initial value: F1,74.1= 19.09, p < 0.001). The LSD tests comparing the 320 control group with each T3 treatment always reported p < 0.001 ( Figure 1B The T3 treatment affected the moult (F3,81= 7.28, p <0.001)birds with higher doses 325 being more frequently engaged in moult (5, 55, 85 and 91% respectively, from controls 326 to higher dosages). Pairwise comparisons were always p < 0.048, excepting at the two 327 highest levels (p = 0.598). No other factor remained in the model (all p > 0.25). 328
Body mass difference 330
At the intermediate measure, the interaction between both treatments was non-significant 331 (p = 0.301). In the best-fitted model, the antioxidant treatment reported a significant effect 332 (Table 1) . MitoTEMPO-treated birds lost less mass than controls (LSM± SE: -0.96 ± 0.09 333 and -1.23 ± 0.09 g, respectively). T3 treatment was also a significant factor (Table 1)  334 because birds in any hormone-treated group lost more mass than controls (all 335 comparisons: p < 0.001; Figure 2A ). The T3-1 vs T3-3 comparison was also significant 336 (p = 0.027). When the final body mass was tested, the treatment interaction reported (p = 337 0.085). Only mitoTEMPO-treated birds not exposed to exogenous T3 increased body 338 mass ( Figure 2B The treatments reported a clear highly significant interaction ( Table 2) CYP2J19 expression at the medium-sized (T3-2) dosage compared to hormone controls 356 (p = 0.014; other comparisons among S-injected birds: p > 0.082). In mitoTEMPO-357 treated birds, the control vs T3-2 reported p = 0.066, suggesting increased gene expression 358 ( Figure 3B ). The value then declined at the highest T3 dosage (T3-1 vs T3-3 and T3-2 vs 359 T3-3: both p-values < 0.027; other comparisons: p-values > 0.17). It is worth noting that 360 when circulating carotenoids at bill sampling time were added as a covariate, they were 361 positively correlated to gene expression (slope ± SE: 0.059 ± 0.029; F1,72.5 = 4.18, p = 362 0.045), but this did not alter the treatment interaction (p = 0.013). 363
Bill redness 365
The interaction between both treatments reported a trend to significance (p = 0.075; Table  366 2; also SM for descriptions on other significant terms). This was driven by differences 367 between antioxidant treatments in the two groups with the larger implants ( Figure 3A) . 368
In serum-injected birds, bill redness increased between T3-2 and T3-3 doses (p =0.024), 369 whereas the opposite pattern was suggested among mitoTEMPO-treated birds (but p = 370 0.135). Moreover, in T3-3-treated individuals, the mitoTEMPO effect showed a trend to 371 significance (p = 0.062), here reversing the positive effect of the hormone on redness. 372 Finally, when CYP2J19 expression level is included as another covariate in the 373 redness model, the interaction became clearly non-significant (p = 0.209), both treatments 374 being subsequently removed (both p > 0.80). This covariate then showed a significant 375 positive relationship with redness (i.e. F1,78 = 5.52, p = 0.021; slope ± SE: 0.242 ± 0.103). 376
The regression on raw data was also significant (r = 0.26, p = 0.017, see Figure 4 and also 377 S3). 378 379 Discussion 380
We have shown that CYP2J19 expression levels at the bill epidermis positively correlates 381 to the expression of a red carotenoid-based trait and that this link is affected by a 382 mitochondrial antioxidant and a thyroid hormone. T3-treated birds as a single group 383 showed higher hormone levels than controls, as well as higher respiratory frequency and 384 body mass loss, being also engaged in moult. These effects are well-supported by avian 2018; also SM) and indicate that implants were effective. Moreover, birds with the longest 387 and shortest T3 implants differed in body mass loss, which suggests that the T3 dosage 388 was also relevant. Bill redness and CYP2J19 expression variability support this view. We 389 should, hence, assume that the lack of significant differences in circulating hormone 390 levels among T3-1 to T3-3 groups was probably due to feedback regulation (Leung, 391 Taylor losing redness), did not alter our results (Table S2 and Figure S2 ). Moreover, this body 402 mass change did not correlate with CYP2J19 expression (covariate always p > 0.80). 403
In regard to CYP2J19, we must first highlight that mitoTEMPO and T3 treatments 404 did not influence circulating carotenoid levels, and the addition of plasma carotenoid 405 values as a covariate to the CYP2J19 model, even when correlated, did not alter the 406 results. Therefore, the experimental effects appear to be, at least partially, independent of Moreover, we detected a significant interaction between mitoTEMPO and T3 412 treatments on CYP2J19 expression, but the results did not follow our initial predictions expression among hormone controls, although this was not reflected in bill redness 415 variability (see also below). Such a ketolase downregulation apparently contradicts the 416 effects of another mito-targeted molecule (mitoQ) that improved zebra finch bill redness 417 (Cantarero & Alonso-Alvarez 2017). We argue that this is a consequence of subtle 418 differences in the action mechanisms of mitoQ and mitoTEMPO. The first is a synthetic 419 ubiquinone that improves electron transfer at the IMM, whereas mitoTEMPO is a 420 superoxide dismutase (SOD) mimetic that favours ubiquinone recycling by reducing 421 Interestingly, in that study, the effect was only detected among the reddest birds at the 440 start of the experiment (supposedly the high-quality animals; Cantarero et al. 2019 441 preprint) . This strongly points to other factors controlling mitoTEMPO action on ketolase 442 activity. Perhaps the answer comes from the mitoTEMPO x T3 interaction here showed. 443
Thus, the mitoTEMPO-induced CYP2J19 downregulation showed in hormone 444 controls disappeared from T3-1 to T3-2 ( Figure 4A The presence of the mito-targeted antioxidant mitoTEMPO at T3-2 dosage reversed the 452 inhibitory effect of T3 and even induced higher ketolase expression compared to hormone 453 controls treated with the antioxidant. Subsequently, at the highest T3 dosage, the birds 454 seem to be able to trigger some compensatory mechanism as CYP2J19 expression 455 apparently increased ( Figure 4A ). 456
Literature from mammalian models supports the capacity of thyroid hormones to 457 mount compensatory/protective responses against its own pro-oxidant effects (e.g. In the model testing the difference between final and initial size-corrected body mass, the 99 backward procedure at p < 0.05 reported that only the hormone treatment factor was retained 100 (Table S1 and Figure S1 ). independently of T3-mediated body mass effects, the interaction becomes significant (Table   120 S1 and Figure S1 ). Here, the antioxidant effect at the highest T3 dosage is clearer (p = 0. In the model testing bill redness ( Table 2 in the main text), the location into the cage affected 149 the dependent variable. The bill of those birds placed at the left side was redder than the bill 150 of birds at the right side (LSM ± S.E.: 1.239 ± 0.157 and 0.699 ± 0.157, respectively). This 151 could perhaps be interpreted as birds in the right side being subtly exposed to higher stress 152 levels inhibiting red colouration production. In this regard, we must note that maintenance 153 work daily made (water and food supply) was always made from the left to the right side of 154 the cage. This may have exposed to birds placed in the right side to higher disturbance as 155 both cage sides were only separated by a grille, the bird on the right side enduring more time 156 of disturbance. This apparently subtle influence did only induce a significant effect in the 157 case of the redness model. 
